biological source
mouse
antibody product type
primary antibodies
clone
CT-3, monoclonal
form
liquid
contains
≤0.1% sodium azide as preservative
species reactivity
mouse, human, rat
manufacturer/tradename
Calbiochem®
storage condition
OK to freeze, avoid repeated freeze/thaw cycles
isotype
IgG1
shipped in
wet ice
Quality Level
General description
Purified mouse monoclonal antibody gernerated by immunizing BALB/c mice with the specified immunogen and fusing splenocytes with NS1 mouse myeloma cells. Recognizes the ~95 kDa the β-subunit of insulin receptor.
Recognizes the ~95 kDa the β-subunit of insulin receptor in IM9 cells, placenta, and fetal liver tissue.
This Anti-Insulin Receptor (β-Subunit) Mouse mAb (CT-3) is validated for use in Frozen Sections, Immunoblotting, IP, Paraffin Sections for the detection of Insulin Receptor (β-Subunit).
Immunogen
Human
a recombinant protein consisting of the C-terminal 100 amino acids of the β-subunit of human insulin receptor fused to GST
Application
Frozen Sections (1:50-1:100)
Immunoblotting (1:200-1:400)
Immunoprecipitation (not recommended)
Paraffin Sections (1:50-1:100, pressure cooker pre-treatment required)
Packaging
Please refer to vial label for lot-specific concentration.
Physical form
In 10 mM PBS, 0.2% BSA, pH 7.4.
Preparation Note
Following initial use, aliquot and freeze (-20°C) for long-term storage. Avoid freeze/thaw cycles. Centrifuge the contents of the vial containing the antibody before use to remove any solution that may have accumulated around or under the cap of the vial during shipment or storage.
Analysis Note
Positive Control
IM-9 lymphocyte cells or placenta or liver tissue
IM-9 lymphocyte cells or placenta or liver tissue
Other Notes
Grigorescu, F., et al. 1987. J.Clin. Endocrinol. Metab.64, 549.
Hari, J. and Roth, R.A. 1987. J. Biol. Chem.262, 15341.
Rosen, O.M. 1987. Science237, 1452.
Morgan, D.O., et al. 1986. Proc. Natl. Acad. Sci. USA83, 328.
Morgan, D.O. and Roth, R.A. 1986. Biochemistry25, 1364.
White, M.F. and Kahn, C.R. 1986. The Enzymes17, 247.
Ganguly, S., et al. 1985. In Current Topics in Cellular Regulation, Academic Press 27, 83.
Grunberger, G., et al. 1984. Science223, 932.
Hari, J. and Roth, R.A. 1987. J. Biol. Chem.262, 15341.
Rosen, O.M. 1987. Science237, 1452.
Morgan, D.O., et al. 1986. Proc. Natl. Acad. Sci. USA83, 328.
Morgan, D.O. and Roth, R.A. 1986. Biochemistry25, 1364.
White, M.F. and Kahn, C.R. 1986. The Enzymes17, 247.
Ganguly, S., et al. 1985. In Current Topics in Cellular Regulation, Academic Press 27, 83.
Grunberger, G., et al. 1984. Science223, 932.
No cross-reactivity with IGF receptors. Will stain IM-9 lymphocyte cells as well as placenta and liver tissue. This antibody is also useful for tyrosine kinase assays for antibody mediated capture on microwell plates. Antibody should be titrated for optimal results in individual systems.
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Toxicity: Standard Handling (A)
未找到合适的产品？
试试我们的产品选型工具.
存储类别
11 - Combustible Solids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
Raju V S Rajala et al.
The Journal of biological chemistry, 277(45), 43319-43326 (2002-09-06)
Recently, we have shown that phosphoinositide 3-kinase (PI3K) in bovine rod outer segment (ROS) is activated in vitro by tyrosine phosphorylation of the C-terminal tail of the insulin receptor (Rajala, R. V. S., and Anderson, R. E. (2001) Invest. Ophthal.
Jennifer H Law et al.
Cancer research, 68(24), 10238-10246 (2008-12-17)
Drugs that target the insulin-like growth factor-I receptor (IGF-IR) and/or insulin receptor (IR) are currently under investigation for a variety of malignancies including breast cancer. Although we have previously reported that IGF-IR expression in primary breast tumors is common, the
Sofie Björner et al.
Oncotarget, 8(6), 9093-9107 (2016-12-29)
Clinical trials examining insulin-like growth factor-I receptor (IGF1R)-targeting strategies have emphasized that better predictive biomarkers are required to improve patient selection.Immunohistochemical tumor-specific protein expression of IGF1R, insulin receptor (InsR), and phosphorylated IGF1R/InsR (pIGF1R/InsR) individually and combined in relation to breast
Sofie Björner et al.
Frontiers in endocrinology, 8, 332-332 (2017-12-14)
The prognostic importance of tumor-specific nuclear insulin receptor (InsR) expression in breast cancer is unclear, while membrane and cytoplasmic localization of InsR is better characterized. The insulin signaling network is influenced by obesity and may interact with the estrogen receptor
Henning Hvid et al.
Journal of applied toxicology : JAT, 31(4), 312-328 (2011-01-25)
Supra-pharmacological doses of the insulin analog X10 (AspB10) increased the incidence of mammary tumors in female Sprague-Dawley rats in chronic toxicity studies, most likely via receptor-mediated mechanisms. However, little is known about the expression of the insulin receptor family in
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持